
Mercy BioAnalytics
Developer of a novel liquid biopsy assay platform designed to relieve suffering and save lives through the early detection of cancer. The company's platform interrogates tumor-derived extracellular ve...
Valuation
$0
Share Price
N/A
Total Raised
$127.3M
Last Round
N/A